Overview

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Status:
Suspended
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
To investigate prospectively whether short term endocrine treatment can induce molecular changes, predictive for therapy response.
Phase:
Phase 2
Details
Lead Sponsor:
The Netherlands Cancer Institute
Collaborator:
AstraZeneca
Treatments:
Anastrozole
Estradiol
Fulvestrant
Hormones
Tamoxifen